The largest increase in unvaccinated children in 20 years and critical gaps in disease surveillance increase risk of measles outbreaks, putting lives at risk: WHO, CDC While reported measles cases have fallen compared to previous […]
• The Scottish Medicines Consortium (SMC) has accepted Bristol Myer Squibb’s (BMS) Zeposia® (ozanimod) for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease as defined by clinical or imaging […]
The UK’s National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s dapagliflozin as a treatment for people with chronic kidney disease (CKD). The UK’s National Institute for Health and Care Excellence (NICE) has […]
Dunad Therapeutics and Novartis have signed a strategic collaboration and license agreement to develop next generation targeted protein degrader therapies. Dunad Therapeutics and Novartis have signed a strategic collaboration and license agreement to develop next […]
Strategikon Pharma announced a major update to their Clinical Maestro® platform including powerful features that accelerate clinical trial planning and sourcing. This release, Clinical Maestro CORE™, focuses on expanding the ease of use and flexibility […]